A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...

Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

Received folinic acid/fluorouracil/oxaliplatin/bevacizumab in first line with initial partial response; progression after 11 ...

The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...